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The neuroscience of Attention Deficit Hyperactivity
Disorder (ADHD) is at a particularly fascinating stage
in its development. On the one hand, there are great
opportunities for increasingly sophisticated and detailed
analyses of  the neurobiological underpinnings of  the
disorder afforded by powerful neuroimaging and genetic
techniques. On the other hand, there is the challenge of
trying to conceptualize a complex, heterogeneous and
‘fuzzy’ developmental disorder in a coherent and neuro-
biologically plausible way so that these opportunities can
be exploited. In this Special Section, we have brought
together a group of leading international scientists in
ADHD from the fields of child psychiatry, paediatrics,
experimental and developmental psychology, neurology,
psychopharmacology and neuroscience to grapple with
this challenge. Their goal was to work in groups across
disciplinary boundaries, not to provide exhaustive reviews
of the field (although, where reviews are included in papers
they are authoritative and wide ranging), but rather to
bring their particular points of view to bear on some of
the key issues associated with the conceptualization of
ADHD and, in so doing, to provide direction for future
study. Through the European Network on Hyperkinetic
Disorder (Eunethydis), of which most are long-standing
associates, the contributors have a track record of under-
taking collaborative studies integrating multiple levels
of analysis (neuroanatomy, genetics, neuropsychology,
neurophysiological and clinical) in an attempt to forge
theoretical links between clinical and fundamental
science. Thus they are perfectly placed to provide the type
of ‘state-of-play’ review required.
In the first paper, Coghill and colleagues provide a broad
examination of the current standing of the science of
ADHD in terms of  its capacity to develop and test
neuroscientifically plausible causal models. These authors
conclude that, while a number of such models have been
proposed, their accuracy has not been demonstrated
empirically. They go on to argue that if  this situation is
to change, a number of specific barriers need to be over-
come. These include the need to properly characterize
the ADHD phenotype for genetic and neurobiological
studies; to break down disciplinary boundaries to allow
work integrating concepts across multiple levels of ana-
lysis, using multiple methods; to recognize the existence
of neuroscientific complexity both in terms of substan-
tial heterogeneity within ADHD samples and significant
overlap between ADHD samples and samples of chil-
dren with other conditions; and to use developmental
approaches that integrate environmental factors into
models of genetic and neurobiological influence on
ADHD. In many ways, this paper represents a manifesto
for the future of research in the neuroscience of ADHD.
Its relevance is highlighted by the way its agenda reson-
ates with the contents of the remaining papers, as these
themes are picked up and discussed from different points.
Stevenson and colleagues address the issue of the ADHD
phenotype. Up to this point, the genetic study of ADHD
has made considerable progress with relatively broad and
unsophisticated phenotypic measures (e.g. rating scale
measures). The authors argue that these measures may need
to be refined if  further progress is to be made, especially
in the area of gene identification. A major concern in this
regard is to reduce genetic heterogeneity and identify
genetic variation that is shared with other disorders and
that which is specific to ADHD. They recommend that
both categorical and dimensional measures should be
employed, defined on the basis of  information from
multiple sources. They also conclude that, despite their
potential value for segregating heterogeneity, attempts
to identify endophenotypes (intermediate processes that
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mediate the causal pathway between susceptibility genes
and the clinical exophenotype) have so far met with limited
success. The authors, while encouraging continuation of
this strategy suggest extending such studies beyond the
cognitive underpinnings of ADHD to include physiological
and metabolic markers. Oades and colleagues ground a
discussion of  these issues within a broad overview of
the neurochemistry and psychopharmacology of  the
catecholamine-based behavioural systems implicated in
ADHD. They highlight the complex role played by
catecholamine neurotransmission in ADHD, as studied
in rodent and primate models and in the clinical con-
dition. Research in the neuropathology of ADHD has
mainly concentrated on pre-frontal executive processes
as modulated by dopamine. The authors remind us of
two things that emphasize the complexity and potential
neurobiological heterogeneity of the condition. First,
that dopamine plays a critical roles in the regulation of
many neural pathways linking sub-cortical with cortical
regions, which play separate and distinct roles in areas
other than executive functioning, for instance in the regula-
tion of reward-related behaviours and the regulation of
the cognitive energetic state. Second, that norepinephrine,
as well as dopamine, plays a key role in modulating these
brain circuits and that an understanding of dopamine 
 
×
 
norepinephrine interactions is likely to be vital in models
of ADHD. Banaschewski and colleagues focus on the issue
of specificity of causal processes by comparing the neuro-
psychological, neurobiological and genetic characteristics
of ADHD with other disorders (including Oppositional
Defiant Disorder, learning disability, autism and schizo-
phrenia). Critically, they provide a case against executive
dysfunction as a specific cause of ADHD. They argue
that there needs to be concerted and systematic study of
the role of  other candidate processes such as timing
deficits, motivational characteristics and state regulation
in the neuropathology of ADHD. Finally, Sonuga-Barke
and colleagues highlight the importance of placing ADHD
within its developmental context. They do this by exploring
the developmental roots of the condition in the preschool
period. By doing this, they highlight the importance
of identifying pathways between risk and later ADHD.
Once again these authors emphasize the developmental
complexity and heterogeneity of the condition.
While the focus in all five papers is on basic science,
the broader framework is translational. The underlying
motivation is to apply findings from the basic sciences to
the clinical condition in a way that facilitates a more
appropriate and informative taxonomy and eventually
more effective treatments for ADHD. The picture that
emerges of ADHD as a disorder with a complex, hetero-
geneous and ‘fuzzy’ psychopathophysiology challenges
current diagnostic conceptualizations regarding the internal
structure of the disorder (e.g. the existence of neuro-
psychological subtypes) and its distinctiveness from other
disorders. At the same time, it presents a stimulus for
further multidisciplinary work to address these emerging
issues.


